This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Digital-droplet PCR assays for IDH, DNMT3A and driver mutations to monitor after allogeneic stem cell transplantation minimal residual disease of myelofibrosis
Bone Marrow Transplantation Open Access 19 January 2022
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Kröger N, Alchalby H, Klyuchnikov E, Badbaran A, Hildebrandt Y, Ayuk F et al. JAK2 V617F-triggered preemptive and salvage adoptive immunotherapy with donor lymphocyte infusion in patients with myelofibrosis after allogeneic stem cell transplantation. Blood 2009; 113: 1866–1868.
Alchalby H, Badbaran A, Zabelina T, Kobbe G, Hahn J, Wolff D et al. Impact of JAK2 V617F mutation status, allele burden, and clearance after allogeneic stem cell transplantation for myelofibrosis. Blood 2010; 116: 3572–3581.
Alchalby H, Badbaran A, Bock O, Fehse B, Bacher U, Zander AR et al. Screening and monitoring of MPL W515Lmutation with real-time PCR in patients with myelofibrosis undergoing allogeneic-SCT. Bone Marrow Transplant 2010; 45: 1404–1407.
Lange T, Edelmann A, Siebolts U, Krahl R, Nehring C, Jakel N et al. JAK2 p.V617F allele burden in myeloproliferative neoplasms one month after allogeneic stem cell transplantation significantly predicts outcome and risk of relapse. Haematologica 2013; 98: 722–728.
Haslam K, Langabeer SE, Molloy K, McMullin MF, Conneally E . Assessment of CALR mutations in myelofibrosis patients, post-allogeneic stem cell transplantation. Br J Haematol 2014; 166: 800–802.
Klampfl T, Gisslinger H, Harutyunyan AS, Nivarthi H, Rumi E, Milosevic JD et al. Somatic mutations of calreticulin in myeloproliferative neoplasms. N Engl J Med 2013; 369: 2379–2390.
Nangalia J, Massie CE, Baxter EJ, Nice FL, Gundem G, Wedge DC et al. Somatic CALR mutations in myeloproliferative neoplasms with unmutated JAK2. N Engl J Med 2013; 369: 2391–2405.
Tefferi A, Pardanani A . CALR mutations and a new diagnostic algorithm for MPN. Nat Rev Clin Oncol 2014; 11: 125–126.
Jones AV, Ward D, Lyon M, Leung W, Callaway A, Chase A et al. Evaluation of methods to detect CALR mutations in myeloproliferative neoplasms. Leuk Res 2015; 39: 82–87.
Sykes PJ, Neoh SH, Brisco MJ, Hughes E, Condon J, Morley AA . Quantitation of targets for PCR by use of limiting dilution. Biotechniques 1992; 13: 444–449.
Vogelstein B, Kinzler KW . Digital PCR. Proc Natl Acad Sci USA 1999; 96: 9236–9241.
Stahl T, Böhme MU, Kröger N, Fehse B . Digital PCR to assess hematopoietic chimerism after allogeneic stem cell transplantation. Exp Hematol 2015; 43: 462–468.
Fiedler W, Henke RP, Ergün S, Schumacher U, Gehling UM, Vohwinkel G et al. Derivation of a new hematopoietic cell line with endothelial features from a patient with transformed myeloproliferative syndrome: a case report. Cancer 2000; 88: 344–351.
Weber K, Mock U, Petrowitz B, Bartsch U, Fehse B . LeGO vectors equipped with novel drug-selectable fluorescent proteins - new building blocks for cell marking and multi-gene analysis. Gene Ther 2010; 17: 511–520.
Acknowledgements
MC has been supported by the Erich und Gertrud Roggenbuck-Stiftung.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Additional information
Supplementary Information accompanies this paper on Bone Marrow Transplantation website
Supplementary information
Rights and permissions
About this article
Cite this article
Badbaran, A., Fehse, B., Christopeit, M. et al. Digital-PCR assay for screening and quantitative monitoring of calreticulin (CALR) type-2 positive patients with myelofibrosis following allogeneic stem cell transplantation. Bone Marrow Transplant 51, 872–873 (2016). https://doi.org/10.1038/bmt.2016.14
Published:
Issue Date:
DOI: https://doi.org/10.1038/bmt.2016.14
This article is cited by
-
Digital-droplet PCR assays for IDH, DNMT3A and driver mutations to monitor after allogeneic stem cell transplantation minimal residual disease of myelofibrosis
Bone Marrow Transplantation (2022)
-
ASXL1/EZH2 mutations promote clonal expansion of neoplastic HSC and impair erythropoiesis in PMF
Leukemia (2019)
-
Impact of molecular residual disease post allografting in myelofibrosis patients
Bone Marrow Transplantation (2017)
-
Similar outcome of calreticulin type I and calreticulin type II mutations following RIC allogeneic haematopoietic stem cell transplantation for myelofibrosis
Bone Marrow Transplantation (2016)
-
Droplet digital PCR assay for quantifying of CALR mutant allelic burden in myeloproliferative neoplasms
Annals of Hematology (2016)